Acute megakaryocytic leukemia: The Eastern Cooperative Oncology Group experience

Blood

Volumn 96, Issue 7, 2000, Pages 2405-2411

  Tallman, M S ^a   Neuberg, D ^a   Bennett, J M ^a   Francois, C J ^a   Paietta, E ^a   Wiernik, P H ^a   Dewald, G ^a   Cassileth, P A ^a   Oken, M M ^a   Rowe, J M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYTARABINE; MYELOPEROXIDASE; T LYMPHOCYTE ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CANCER SURVIVAL; CHROMOSOME 3; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKEMIA REMISSION; MALE; MYELOFIBROSIS; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTHRACYCLINES; ANTIGENS; ANTIGENS, CD2; ANTIGENS, CD7; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD PLATELETS; BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; CYTARABINE; FEMALE; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; MALE; MIDDLE AGE; PEROXIDASE; RANDOMIZED CONTROLLED TRIALS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0034307375     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Uber einen fall von akuter megakaryocyblasten-leukamie, zugleich einige bemerkungen zum Problem der akuten leukemie
2. Megakaryoblastic acute leukemia: Identification by the ultrastructural demonstration of platelet peroxidase
3. Megakaryoblastic leukemia presenting as acute myelofibrosis - A study of four cases with the platelet-peroxidase reaction
4. Leukaemia of platelet precursors: Diverse features in four cases
5. Megakaryocylic leukemia: Identification utilizing anti-factor VIII immunoperoxidase
6. Reversal of marrow fibrosis in acute megakaryoblastic leukemia after remission-induction and consolidation chemotherapy followed by bone marrow transplantation
7. Acute megakaryoblastic leukemia
8. Acute leukemia with megakaryocytic differentiation: A study of 12 cases identified immunocytochemical
9. Acute megakaryoblastic leukemia: A prospective study of its identification and treatment
10. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): A report of the French-American-British Cooperative Group
11. Hematologic malignancies associated with primary mediastinal germ-cell tumors
12. Malignant disorders of megakaryocytes associated with primary germ cell tumors
13. Mediastinal germ cell tumor and acute megakaryoblastic leukemia
14. Megakaryoblastic leukemia and Down's syndrome: A review
15. Acute myelofibrosis in children with Down's syndrome
16. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults: Analysis of 49 patients
17. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorders and megakaryoblastic leukemia in Down's syndrome
18. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome
19. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome
20. Nouveau-ne trisomique 21, proliferation trisomique 21, proliferation megacaryocyto-plaquettaire: Syndrome de coagulation intravescular e diffuse
21. Acute megakaryoblastic leukemia associated with intrinsic platelet dysfunction and constitutional ring 2 chromosome in a young boy
22. Leukemia with megakaryoblastic involvement: Clinical, hematological and immunological characteristics
23. Diagnosis of megakaryoblastic leukemia
24. Multipotent stem cell involvement in megakaryoblastic leukemia: Cytologic and cytogenetic evidence in 15 patients
25. Target cell of leukemic transformation in acute megakaryocytic leukemia
26. Long-term treatment results for acute megakaryoblastic leukemia patients: A multicentre study
27. Acute megakaryoblastic leukemia in children and adolescents: A retrospective analysis of 24 cases
28. Postremission therapy in adults with acute myelogenous leukemia: The Eastern Cooperative Oncology Group (ECOG) experience
29. Long-term survival in acute myeloid leukemia
30. Acute leukemia of megakaryocytic lineage (M7)
31. Quantification of bone marrow reticulin - A normal range
32. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: The Eastern Cooperative Oncology Group experience
33. Immunology of acute leukemia
34. Varying intensity of post-remission therapy in acute myeloid leukemia
35. A randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (>55-70 years of age) with acute myelogenous leukemia: A study of the Eastern Cooperative Oncology Group (E1490)
36. Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: The ECOG experience
37. Autologous transplant in acute myeloid leukemia in first remission
38. A comparison of chemotherapy versus autologous bone marrow transplantation versus allogeneic bone marrow transplantation in first remission of adult acute myeloid leukemia: An intergroup study (E3489)
39. Feasibility study of adding high-dose cytarabine (HDAC) in induction (IND) and in consolidation transplant (ASCT) in adult acute myeloid leukemia
40. Characterization of an acute micromegakaryocytic leukemia: Evidence for the pathogenesis of myelofibrosis
41. Acute megakaryocytic leukemia in children: Clinical immunologic and cytogenetic findings in two patients
42. Acute megakaryoblastic leukemia with massive myelofibrosis: Complete remission and reversal of marrow fibrosis with allogeneic bone marrow transplantation as the only treatment
43. Cytogenetic findings in acute megakaryoblastic leukemia (ANLL-M7)
44. Myeloproliferative disorders terminating in acute megakaryoblastic leukemia with chromosome 3 or 26 abnormality
45. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome
46. Acute megakaryoblastic leukemia in infants with t(1;22) (p13;q13) abnormality
47. The translocalion t(1;22) (p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children
48. The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryocytic: A pediatric oncology group study
49. Acute megakaryocytic leukemia (AMKL) with major myelofibrosis in an infant: Diagnosis by liver biopsy and response to treatment
50. Acute megakaryocytic leukemia (M7) in children
51. Expression of CD34 and platelet gycoproteins during human megakaryocytic differentiation
52. Characterization of glycoprotein IIb/IIIa - Positive cells in human umbilical cord blood: Their potential usefulness as megakaryocyte progenitors
53. CD34+ megakaryoblastic leukemic cells are CD38-, but CD61+ and glycophorin A+: Improved criteria for diagnosis of AML-M7?
54. Megakaryoblastic leukemia (acute myelofibrosis): A report of three cases
55. Malignant myelofibrosis (acute myelofibrosis): Report of 2 cases following cytotoxic chemotherapy
56. Acute myelodysplasia with myelofibrosis: A report of eight cases
57. Acute myelofibrosis terminating as acute myeloblastic leukemia
58. Acute ('malignant') myelosclerosis
59. Malignant myelosclerosis: Myeloproliferative disorder or leukemia?
60. Multipotent stem cell involvement in megakaryoblastic leukemia: Cytologic and cytogenetic evidence in 15 patients
61. The World Health Organization classification of hematological malignancies: Report of the Clinical Advisory Committee
62. Acute myelofibrosis: Immunohistochemical study of four cases and comparison with acute megakaryocytic leukemia
63. Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first
64. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21;q26) or t(3;3)(q21;q26)
65. Acute megakaryocytic leukemia
66. Cytogenetics of acute leukemia
67. A review of the cytogenetic changes in acute megakaryoblastic leukemia: One disease or several?
68. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26q syndrome
69. Rearrangements of chromosome 3 involving 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia
70. Mixed phenotype of blasts in acute megakaryocytic leukemia and transient abnormal myelopoiesis in Down's syndrome
71. Reversal of marrow fibrosis in acute megakaryoblastic leukaemia after remission-induction and consolidation chemotherapy followed by bone marrow transplantation
72. Effect of recombinant human interferons in inducing differentiation of acute megakaryoblastic leukemia blast cells
73. Effect of arsenic trioxide on viability, proliferation and apoptosis in human megakaryocytic leukemia cell lines